These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 12468542)
1. 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. Shumway SD; Li Y; Xiong Y J Biol Chem; 2003 Jan; 278(4):2089-92. PubMed ID: 12468542 [TBL] [Abstract][Full Text] [Related]
2. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. Li Y; Inoki K; Vacratsis P; Guan KL J Biol Chem; 2003 Apr; 278(16):13663-71. PubMed ID: 12582162 [TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785 [TBL] [Abstract][Full Text] [Related]
4. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins. Nellist M; Goedbloed MA; Halley DJ Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161 [TBL] [Abstract][Full Text] [Related]
5. Regulation of TSC2 by 14-3-3 binding. Li Y; Inoki K; Yeung R; Guan KL J Biol Chem; 2002 Nov; 277(47):44593-6. PubMed ID: 12364343 [TBL] [Abstract][Full Text] [Related]
6. Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex. Murthy V; Han S; Beauchamp RL; Smith N; Haddad LA; Ito N; Ramesh V J Biol Chem; 2004 Jan; 279(2):1351-8. PubMed ID: 14559897 [TBL] [Abstract][Full Text] [Related]
7. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. Aicher LD; Campbell JS; Yeung RS J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. Tee AR; Anjum R; Blenis J J Biol Chem; 2003 Sep; 278(39):37288-96. PubMed ID: 12867426 [TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the interaction between tuberin and 14-3-3zeta. Nellist M; Goedbloed MA; de Winter C; Verhaaf B; Jankie A; Reuser AJ; van den Ouweland AM; van der Sluijs P; Halley DJ J Biol Chem; 2002 Oct; 277(42):39417-24. PubMed ID: 12176984 [TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809 [TBL] [Abstract][Full Text] [Related]
13. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832 [TBL] [Abstract][Full Text] [Related]
14. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. Lu Z; Hu X; Li Y; Zheng L; Zhou Y; Jiang H; Ning T; Basang Z; Zhang C; Ke Y J Biol Chem; 2004 Aug; 279(34):35664-70. PubMed ID: 15175323 [TBL] [Abstract][Full Text] [Related]
16. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. Gan B; Melkoumian ZK; Wu X; Guan KL; Guan JL J Cell Biol; 2005 Aug; 170(3):379-89. PubMed ID: 16043512 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Li Y; Inoki K; Guan KL Mol Cell Biol; 2004 Sep; 24(18):7965-75. PubMed ID: 15340059 [TBL] [Abstract][Full Text] [Related]
19. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917 [TBL] [Abstract][Full Text] [Related]
20. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]